Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast,

Renub Research www.renub.com

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

Renub Researchwww.renub.com

Published: August, 2015 Copyright © 2015 Renub Research – All Rights Reserved


Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

Market for Hepatitis C drugs has grown with a

phenomenal rate of more than US$ 13 Billion, in

the year 2014 compared to 2013. In the last two

years a couple of new drugs have been

introduced in the market which has become a

huge success and they have captured maximum

market share of the Hepatitis C market.


Continue (www.renub.com)

Gilead currently dominates the multi-billion dollar

Hepatitis C market, but AbbVie has been trying to

increase its market share since U.S. regulators

approved the marketing of its Viekira Pak. Drug

makers are already focusing on introducing new

drugs in the market as several drugs are standing

in the pipeline. Hepatitis C Drugs is anticipated to

be a rosy market for future period.



This is 3rd edition report on Hepatitis C Drugs Industry.

Report titled “Hepatitis C Market & Forecast, Hepatitis C

Pipeline Drugs Sales & Forecast, Clinical Trials -

Global” provides a comprehensive assessment of the fast-

evolving, high-growth of Hepatitis sector. This 87 page report

with 18 Figures and 1 Table studies the Hepatitis C Drug

Market Landscape.



1.Hepatitis C Drugs Market & Forecast (Chapter 2)

2.Hepatitis C Approved Drugs Sales & Forecast

(Chapter 3)

3.Hepatitis C – Pipeline Drugs Sales & Forecast

(Chapter 4)

4.Hepatitis C Deals & Acquisitions (Chapter 5)

5.Hepatitis C – Company Wise Clinical Trial Analysis

(Chapter 6)



Hepatitis C – Approved Drugs Sales & Forecast (To

2020) (Chapter No. 3)

1. Pegasys

2. Pegintron

3. Incivek

4. Victrelis

5. Olysio

6. Sovaldi/Harvoni

7. HCV Franchise

8. Viekira Pak



Hepatitis C – Pipeline Drugs Sales Forecast (To

2020) (Chapter No. 4)

1. Drug A (Merck & Co. Inc.)

2. Drug B (Merck & Co. Inc.)

3. Drug C (Bristol-Myers Squibb)



Hepatitis C – Company Wise Clinical Trial Analysis

(Chapter No.5)

1. AbbVie

2. Bristol-Myers Squibb (BMS)

3. Gilead Sciences

4. Merck & Co. Inc.

5. Tibotec/Janssen Therapeutics


Order Form

Scan and e-mail this page to [email protected],

alternatively one can also write the Contact Information in

an e-mail and mail it. Else you can also fax this form to

+91-120-424-9780

Questions? Please call

+1-678-302-0700 (USA)

+91-120-421-9822 (India), ,+91-120-424-9780

or mail to [email protected]

mailto:[email protected]



Format

Report Title: Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

For More

Details:http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User

License)

US$ 1290 US$ 1390 US$ 1440 US$ 2090


For ordering this report: Easy ways to place your order

Order online by Credit Card (Visa,

MasterCard, etc.):

http://www.renub.com/hepatitis-c-market-and-forec

ast-hepatitis-c-pipeline-drugs-sales-and-forecast-cli

nical-trials-global-466-p.php

http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php




Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India


Contact Information

First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:


Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor,

C-86, Sector-10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)


Documents

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast,